Metabolic Technologies has launched a new website for its MyoeDge product, a combination of vitamin D3 and calcium beta-hydroxy-beta-methylbutyrate (HMB).
Metabolic Technologies, Inc. (MTI; Ames, IA) has debuted a new website for its MyoeDge formula, a combination of vitamin D3 and calcium beta-hydroxy-beta-methylbutyrate (HMB) that it is promoting on the sports-nutrition market. The newly launched site includes ingredient details, research data, and licensing information for MyoeDge.
MTI explains that while HMB supplementation has been relatively well-researched for offering improvements to lean muscle mass, strength gains, and recovery combined with intense training, the benefits of combining it with vitamin D3 have only become apparent recently. The new website is designed to explain the benefits of the combination.
For instance, results of a 2016 prospective study published on the site suggests elderly women who supplemented with HMB, protein, and vitamin D3 experienced significant increases in strength while recovering from orthopedic surgery for hip fracture.
“The goal of the MyoeDge website is to provide vital information to consumers regarding the ingredients comprising MyoeDge and the science behind those ingredients,” MTI explained, in the website announcement. “Consumers can then make an informed decision about their nutritional supplement regimen.”
The website can be found here: www.myoedge.com.
Nutritional Outlook Magazine